Key result
NSTEMI is linked to ~74% lower in-hospital mortality than STEMI in clopidogrel-treated patients.
Why the study?
Does the use of various in-hospital drugs reduce in-hospital mortality differently in patients with STEMI compared to NSTEMI?
Observational (n=416)
No
Does the use of various in-hospital drugs reduce in-hospital mortality differently in patients with STEMI compared to NSTEMI?
In-hospital use of clopidogrel was associated with a significantly lower mortality rate in NSTEMI compared to STEMI patients, while heparin, nitrates, and statins reduced mortality regardless of MI type.
Answers are grounded in this paper and cite their sources.
Supports potent P2Y12 inhibitors over clopidogrel in STEMI; challenges assumed equivalence across ACS and extends variability research.
We examined 416 patients with acute myocardial infarction. 249 patients had STEMI and 167 NSTEMI. 227 were men and 189 women. 142 men had STEMI and 85 men had NSTEMI. 107 women were diagnosed with STEMI and 82 with NSTEMI. 22.5% of patient with STEMI and 20.2% of patients with NSTEMI died (p = 0.58). We compared the effect of anticoagulant treatment, clopidogrel, salicylate, nitrate, beta-blocker, angiotensin-converting enzyme inhibitor, statin and trimetazidine therapy on mortality in function of the type of myocardial infarction. There were no differences between mortality of patients with STEMI and NSTEMI with respect of use of heparine, salicylate, nitrate, beta-blocker, ACE inhibitor, statin and trimetazidine. While examining the effect of clopidogrel, we observed a significantly lower mortality rate in patients with NSTEMI compared to the STEMI group (p = 0.005). These differences are due to the known variability in clopidogrel absorption and metabolism, which could be influenced by the type of myocardial infarction.
No takes yet. Share an insight, caveat, or question.
Vincze et al. (2014) conducted an observational in Acute myocardial infarction (STEMI or NSTEMI) (n=416). Clopidogrel vs. STEMI vs NSTEMI patients receiving clopidogrel was evaluated on In-hospital mortality among patients receiving clopidogrel (p=0.05). Among patients receiving clopidogrel, in-hospital mortality was lower in patients with NSTEMI compared to those with STEMI.
Synapse has enriched 10 related papers. Consider them for comparative context: